Neolactosylceramide and isoglobosylceramide are two examples of oligoglycosylceramides associated with different pathologies of the central nervous system. Considering their structure, how many possible fragments can be presented via MHC class I and/or II from these specific examples and in general for all oligoglycosyceramides? Explain your answer.